Gary Beale is a MedTech entrepreneur and Chief Executive Officer of Novosound Health, where he is spearheading the creation of a new ultrasound driven health sensing platform for wearables and clinical applications. He has repositioned the company from industrial sensing into a health focused MedTech business addressing one of the most significant unmet needs in wearables: clinically meaningful physiological insight.

Gary was Chief Executive Officer and Founder of Emblation, where he led the creation and commercialisation of novel microwave based therapies across oncology, podiatry, and dermatology applications. His work in energy based medical technology has resulted in over 200 named patents, spanning core energy delivery systems, clinical applications, and device architectures, many of which progressed into regulated medical products with international clinical and commercial adoption.

He is recognised for building IP led MedTech businesses, aligning deep technology innovation with disciplined commercial execution, and shaping organisations capable of scaling from research through to regulated healthcare products. His work sits at the intersection of advanced sensors, energy based medical systems, digital health, and next generation wearable platforms.